About 200 reports

  • VECTORS USED IN GENE THERAPY
  • Types of Gene Therapy

Gene therapy is an experimental technique that encompasses the replacement of mutated genes with healthy genes. Gene therapy is considered to be an effective treatment for chronic diseases as they cause minimum side effects with maximum efficacy and may help in an eradication of disease at a root cause level. It’s an experimental technique...

  • Gene Therapy
  • Boehringer Ingelheim GmbH
  • Celgene Corporation
  • Genzyme Corporation
  • Intrexon Corporation
  • CANCER GENE THERAPY IN AMERICAS
  • CANCER GENE THERAPY MARKET IN APAC

About Cancer Gene Therapy Cancer gene therapy is the treatment of cancer through gene therapy. The therapy uses genetically engineered vectors mostly viruses to deliver a gene into the individual’s body. It can be used for both the prevention and treatment of disease. The major therapies used for the treatment are oncolytic virotherapy,...

  • Gene Therapy
  • World
  • Forecast
  • Market Size
  • Celgene Corporation

Global & US Gene Therapy Market Forecast to 2020 ##.

  • Biological Therapy
  • Gene Therapy
  • United States
  • World
  • Market Size

Spark Therapeutics About Gene Therapy Gene therapy is one of the most recent innovations in the pharmaceutical industry for the treatment of serious, life-threatening diseases, typically in the areas of oncology and cardiovascular.

  • Gene Therapy
  • Therapy
  • World
  • Market Size
  • GENE THERAPY RESEARCH INSTITUTION
  • CELL AND GENE THERAPY CATAPULT

The Global Gene Therapy Partnering Agreements 2010-2018 report provides an understanding and access to the gene therapy partnering deals and agreements entered into by the worlds leading healthcare companies. Trends in gene therapy partnering deals Disclosed headlines, upfronts, milestones and royalties by stage...

  • Biological Therapy
  • Gene Therapy
  • World
  • Demand

Gene Therapy R& D and Revenue Forecasts 2018-2028 ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Forecast
  • Market Size

As gene therapies are generally meant for one time or short duration treatments, they are customized to individuals confined to small patient populations.

  • Biological Therapy
  • Gene Therapy
  • Therapy
  • World
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA
  • OVERVIEW: GENE THERAPY FOR HEMOPHILIA A

Hemophilia Gene Therapy: An insight Hemophilia is an inherited bleeding disorder. The gene responsible for hemophilia is present on the X chromosome and is inherited in a recessive manner. Hemophilia A, also called as factor VIII (FVIII) deficiency or classic hemophilia, is caused by missing or defective factor VIII. Most individuals,...

  • Gene Therapy
  • Alnylam Pharmaceuticals, Inc.
  • Baxter International Inc.
  • Pharming Group NV
  • uniQure N.V.

Gene Therapy in CVMD

7268 7995 6178
  • OVERVIEW - CVMD GENE THERAPY
  • Oversight of Gene Therapy in Japan

Gene Therapy in CVMD Summary Gene therapies have been a point of discussion during the last several years as a potential curative option for a variety of disease indications.While mainly still in preclinical stages, gene therapy aims to treat or alleviate a disease by genetically modifying the cells...

  • Gene Therapy
  • United States
  • AnGes MG, Inc.
  • Juventas Therapeutics, Inc.
  • ViroMed Co., Ltd.
  • CANCER GENE THERAPY STRATEGIES
  • WHAT IS GENE THERAPY?

Gene Therapy in Oncology Summary Gene therapy refers to any procedure that aims to treat or alleviate a disease by genetically modifying the cell of a patient. The material to be transferred may consist of genes, gene segments, or oligonucleotides and target cells may be normal cells, cancerous cells,...

  • Biological Therapy
  • Biotechnology
  • Gene Therapy
  • Therapy
  • United States
  • GENE THERAPY
  • GENE THERAPY

INTRODUCTION The concept of gene transfer into mammalian cells can be traced back to the 1920s. However, the first gene therapy, Gendicine®, was only approved in 2003 in China; since then, the domain has evolved significantly. The year 2017 was particularly eventful; despite the withdrawal of Glybera® from the European...

  • Gene Therapy
  • North America
  • United States
  • Company
  • Market Size
  • Mucopolysaccharidoses gene therapy molecules by disease type
  • Global mucopolysaccharidoses gene therapy: An overview of pipeline molecules

This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy for mucopolysaccharidosis including molecules at pre-clinical and various other development stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations...

  • Gene Therapy
  • Therapy
  • United States
  • Abeona Therapeutics, Inc.
  • RegenxBio Inc.
  • Ovarian cancer gene therapy: An overview of pipeline
  • Segmentation of ovarian cancer gene therapy pipeline by type of disease

This pipeline analysis report provides detailed insights into the clinical trials landscape of the gene therapy for ovarian cancer including molecules at various development stages. The report also offers comprehensive information about the therapeutic assessment of the pipeline molecules based on various segmentations such as route of administration...

  • Gene Therapy
  • United States
  • Advantagene, Inc.
  • Celsion Corporation
  • Takara Bio Inc.

Cancer Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ## INTRODUCTION ##. ##.

  • Cancer Gene Therapy
  • Gene Therapy
  • APAC
  • World
  • Market Size

Gene Therapy Market - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ##: INTRODUCTION ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Market Size

Combination of gene therapy with small molecules or protein therapy is said to have lesser side effects and better efficacy as compared to gene therapy alone.

  • Biological Therapy
  • Gene Therapy
  • United States
  • Market Size

Gene Therapy Market by Vector Type, Gene Type and Applications - Global Opportunity Analysis and Industry Forecast, 2017-2023 CHAPTER ##: INTRODUCTION ##. ##.

  • Biological Therapy
  • Gene Therapy
  • Market Size

Global Gene Therapy Market Forecast to 2020 ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Market Size
  • 7.1.9 CELL AND GENE THERAPIES, BY PRODUCT
  • Middle East & Africa Cell and Gene Therapies Market by Geography

The global biopharmaceuticals market is estimated to reach USD 341.16 billion in 2023. The market is expected to register a CAGR of 8.5% during the forecast period (2018 – 2023). North America dominates the market due to rapid technological advancements. Increasing Acceptance for Biopharmaceuticals and Significant Market Demand Opportunities...

  • Biopharmaceutical
  • Biotechnology
  • Gene Therapy
  • World
  • Market Size

Gene Therapy: Moving Towards Commercialization Table of Contents Executive Summary vi The potential near-term success of ex vivo gene therapies xxii Outlook for gene therapy xxv CHAPTER ##: History of Gene Therapy ## Ear

  • Biological Therapy
  • Gene Therapy

The current pipeline for gene therapies is diverse in terms of the approaches and vectors covered; ##% are gene silencing therapies, while ##% involve the insertion of a functional gene - - In which therapy areas is there the highest level of R&a

  • Biological Therapy
  • Gene Therapy
  • Market Size

BIOVIAN BOEHRINGER INGELHEIM GMBH BRAMMER BIO CELL AND GENE THERAPY CATAPULT CEVA CORPORATE COBRA BIOLOGICS (SUBSIDIARY OF RECIP AB) CREATIVE BIOGENE GE HEALTHCARE GENEDETECT GENVEC INC.

  • Gene Therapy
  • Pathology
  • Viral Vector
  • World
  • Market Size

CELL AND GENE THERAPY CATAPULT ##. ##.

  • Gene Therapy
  • Vaccine
  • Viral Vector
  • World
  • Market Size

Gene Therapy Pipeline Molecules ##.

  • Gene Therapy
  • APAC
  • World
  • Forecast
  • Market Size
  • GENE THERAPY RESEARCH INSTITUTE / AGILIS BIOTHERAPEUTICS
  • PRODUCTS, 2018-2030: DISTRIBUTION BY APPLICATION (GENE THERAPY / T-CELL THERAPY)

INTRODUCTION Genetically modified therapies have emerged as a promising treatment option for various diseases (primarily ones that currently have no cure), including cancers, inherited disorders and certain viral infections. These therapies have demonstrated the potential to treat chronic indications, such as Alzheimer’s...

  • Gene Therapy
  • United States
  • Market Size
  • Lonza Group Ltd
  • Sanofi S.A.

Glybera, a gene therapy for lipoprotein lipase deficiency, was recently launched in Germany at a price of more than ## million euros ($##. ## million).

  • Biological Therapy
  • Gene Therapy
  • Europe
  • European Union
  • United States
  • 9.7 BENITEC BIOPHARMA LTD
  • 7.4 REST OF THE WORLD

RNAi Technology Market The market for RNAi technology is estimated to be USD 12.56 billion in 2016 and is expected to reach USD 31.52 billion by 2021, growing at a CAGR of 20.19% RNA interference (RNAi) is a natural process of treating forms of cancer and other diseases by post-transcriptional silencing of genes by small fragments...

  • Gene Therapy
  • World
  • Alnylam Pharmaceuticals, Inc.
  • Arcturus Therapeutics, Inc.
  • Sirna Therapeutics, Inc.

CELL AND GENE THERAPY CATAPULT ##. ##.

  • Gene Therapy
  • Viral Vector
  • North America
  • Forecast
  • Market Size

CELL AND GENE THERAPY CATAPULT ##. ##.

  • Gene Therapy
  • Vaccine
  • Viral Vector
  • Europe
  • Market Size

Global Gene Therapy Market & Pipeline Insight ##.

  • Biological Therapy
  • Gene Therapy
  • World
  • Market Size